Oxford Pharmaceuticals Chairman Testifies Before U.S. Senate on Domestic Generic Drug Manufacturing Crisis
Tom Neely, chairman of Oxford Pharmaceuticals, testified Wednesday before the U.S. Senate Special Committee on Aging, urging Congress to recognize generic pharmaceuticals as critical national security infrastructure and implement policies that would enable domestic manufacturers to compete against heavily subsidized foreign producers.
